Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer
Authors
Keywords
Autophagy, Apoptosis, ABT-737, Chloroquine, Primary xenograft
Journal
Molecular Cancer
Volume 12, Issue 1, Pages 16
Publisher
Springer Nature
Online
2013-03-03
DOI
10.1186/1476-4598-12-16
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential effects of the autophagy inhibitors 3-methyladenine and chloroquine on spontaneous and TNF-α-induced neutrophil apoptosis
- (2012) Boris K. Pliyev et al. APOPTOSIS
- Guidelines for the use and interpretation of assays for monitoring autophagy
- (2012) Daniel J. Klionsky et al. Autophagy
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells
- (2012) Xian-ling Guo et al. CANCER LETTERS
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Autophagy and cancer therapy
- (2011) Paola Maycotte et al. CANCER BIOLOGY & THERAPY
- Autophagy as a therapeutic target in cancer
- (2011) Ning Chen et al. CANCER BIOLOGY & THERAPY
- Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
- (2011) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
- (2011) Leena Gandhi et al. JOURNAL OF CLINICAL ONCOLOGY
- BH3 mimetics activate multiple pro-autophagic pathways
- (2011) S A Malik et al. ONCOGENE
- The Bcl-2 Homology Domain 3 Mimetic Gossypol Induces Both Beclin 1-dependent and Beclin 1-independent Cytoprotective Autophagy in Cancer Cells
- (2010) Ping Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Autophagy by 3-MA Enhances the Effect of 5-FU-Induced Apoptosis in Colon Cancer Cells
- (2009) Jie Li et al. ANNALS OF SURGICAL ONCOLOGY
- A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
- (2009) V. C. Daniel et al. CANCER RESEARCH
- The Double-Edged Sword of Autophagy Modulation in Cancer
- (2009) E. White et al. CLINICAL CANCER RESEARCH
- Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies
- (2009) V. Raja Solomon et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function
- (2009) I A Ciechomska et al. ONCOGENE
- Autophagy: Basic Principles and Relevance to Disease
- (2008) Mondira Kundu et al. Annual Review of Pathology-Mechanisms of Disease
- Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer
- (2008) C. L. Hann et al. CANCER RESEARCH
- Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells
- (2008) Takashi Shingu et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started